Drugs / Triamcinilone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00941473 Comparator | Jul 2007 → Jul 2011 | — | Henry Ford Health System | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Triamcinilone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00941473 ↗ |
| Known as | kenalog | “Triamcinilone (kenalog)” NCT00941473 ↗ |
| Route | Other | “Epidural steroid injection of 80mg of Triamcinilone.” NCT00941473 ↗ |